These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 24708056)
1. In vitro evaluation of optimized liposomes for delivery of small interfering RNA. Yang T; Bantegui T; Pike K; Bloom R; Phipps R; Bai S J Liposome Res; 2014 Dec; 24(4):270-9. PubMed ID: 24708056 [TBL] [Abstract][Full Text] [Related]
2. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF. Şalva E; Turan SÖ; Eren F; Akbuğa J Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of VEGF expression in A431 and MDA-MB-231 tumour cells by cationic lipid-mediated siRNA delivery. Briane D; Slimani H; Tagounits A; Naejus R; Haddad O; Coudert R; Charnaux N; Cao A J Drug Target; 2012 May; 20(4):347-54. PubMed ID: 22475204 [TBL] [Abstract][Full Text] [Related]
4. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery. Chen CW; Yeh MK; Shiau CY; Chiang CH; Lu DW Int J Nanomedicine; 2013; 8():2613-27. PubMed ID: 23901275 [TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of small interfering RNA to angiogenic endothelial cells with liposome-polycation-DNA particles. Vader P; Crielaard BJ; van Dommelen SM; van der Meel R; Storm G; Schiffelers RM J Control Release; 2012 Jun; 160(2):211-6. PubMed ID: 21983283 [TBL] [Abstract][Full Text] [Related]
6. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression. Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682 [TBL] [Abstract][Full Text] [Related]
7. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. Kim HK; Davaa E; Myung CS; Park JS Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025 [TBL] [Abstract][Full Text] [Related]
8. Co-delivery of gambogenic acid and VEGF-siRNA with anionic liposome and polyethylenimine complexes to HepG2 cells. Yu Q; Zhang B; Zhou Y; Ge Q; Chang J; Chen Y; Zhang K; Peng D; Chen W J Liposome Res; 2019 Dec; 29(4):322-331. PubMed ID: 29745740 [No Abstract] [Full Text] [Related]
9. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes. Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333 [TBL] [Abstract][Full Text] [Related]
10. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide. Lee SH; Kim SH; Park TG Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451 [TBL] [Abstract][Full Text] [Related]
11. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab. Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of VEGF-siRNA/CRS as a novel vector for gene delivery. Zhao W; Zhang Y; Jiang X; Cui C Drug Des Devel Ther; 2016; 10():3851-3865. PubMed ID: 27920500 [TBL] [Abstract][Full Text] [Related]
14. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Li SD; Huang L Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857 [TBL] [Abstract][Full Text] [Related]
15. Anionic amino acid-derived cationic lipid for siRNA delivery. Suh MS; Shim G; Lee HY; Han SE; Yu YH; Choi Y; Kim K; Kwon IC; Weon KY; Kim YB; Oh YK J Control Release; 2009 Dec; 140(3):268-76. PubMed ID: 19567256 [TBL] [Abstract][Full Text] [Related]
16. Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes. Golkar N; Samani SM; Tamaddon AM Int J Pharm; 2016 Aug; 510(1):30-41. PubMed ID: 27291973 [TBL] [Abstract][Full Text] [Related]